Mondelez International Total Cost of Revenue decreased by 3.5% to $7.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.7%, from $6.88B to $7.28B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 12.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.01B | $4.36B | $4.83B | $4.78B | $4.63B | $5.15B | $5.62B | $5.72B | $5.15B | $5.54B | $5.84B | $4.54B | $5.55B | $6.21B | $5.89B | $6.88B | $6.05B | $7.13B | $7.54B | $7.28B |
| QoQ Change | — | +8.7% | +10.7% | -0.9% | -3.1% | +11.2% | +9.1% | +1.8% | -9.9% | +7.4% | +5.6% | -22.3% | +22.2% | +11.9% | -5.0% | +16.8% | -12.1% | +17.9% | +5.7% | -3.5% |
| YoY Change | — | — | — | — | +15.5% | +18.2% | +16.5% | +19.6% | +11.2% | +7.5% | +4.0% | -20.6% | +7.6% | +12.1% | +0.8% | +51.6% | +9.0% | +14.9% | +27.9% | +5.7% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Europe | $2.54B | $2.34B | $2.79B | $3.16B | $2.90B |
| North America | $1.58B | $1.62B | $1.77B | $1.82B | $1.63B |
| AMEA | $1.27B | $1.19B | $1.38B | $1.48B | $1.56B |
| Latin America | $815.00M | $807.00M | $849.00M | $844.00M | $911.00M |
| Total | $6.88B | $6.05B | $7.13B | $7.54B | $7.28B |